Cooper Companies Past Earnings Performance
Past criteria checks 1/6
Cooper Companies's earnings have been declining at an average annual rate of -2.5%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 8.4% per year. Cooper Companies's return on equity is 3.8%, and it has net margins of 7.9%.
Key information
-2.5%
Earnings growth rate
-2.5%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 8.4% |
| Return on equity | 3.8% |
| Net Margin | 7.9% |
| Next Earnings Update | 30 May 2024 |
Recent past performance updates
Recent updates
Should You Think About Buying The Cooper Companies, Inc. (NASDAQ:COO) Now?
Apr 17
The Cooper Companies: Rating Upgrade As Near-Term Momentum Should Continue
Mar 22Calculating The Intrinsic Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Mar 18The Cooper Companies: I Still Don't See Much Upside
Mar 01These 4 Measures Indicate That Cooper Companies (NASDAQ:COO) Is Using Debt Reasonably Well
Jan 23Cooper Companies: Women Health Business Makes Room For Growth; Path For Margin Expansion
Jan 15When Should You Buy The Cooper Companies, Inc. (NASDAQ:COO)?
Jan 08With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
Dec 24A Look At The Fair Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Nov 30Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
Oct 30What Does The Cooper Companies, Inc.'s (NASDAQ:COO) Share Price Indicate?
Sep 28Cooper Offers A Great Business But A Somewhat Tricky Valuation
Sep 25Here's Why Cooper Companies (NYSE:COO) Can Manage Its Debt Responsibly
Sep 10Calculating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Aug 23Cooper Companies (NYSE:COO) Is Reinvesting At Lower Rates Of Return
Jul 24The Cooper Companies: Valuation Is Too High (Rating Downgrade)
Jul 12When Should You Buy The Cooper Companies, Inc. (NYSE:COO)?
Jun 24Is Cooper Companies (NYSE:COO) Using Too Much Debt?
Jun 08Estimating The Intrinsic Value Of The Cooper Companies, Inc. (NYSE:COO)
May 24Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Apr 23At US$355, Is The Cooper Companies, Inc. (NYSE:COO) Worth Looking At Closely?
Mar 25These 4 Measures Indicate That Cooper Companies (NYSE:COO) Is Using Debt Reasonably Well
Feb 04Cooper Companies: Growth Comes At A High Cost To Equity Holders, Rate Hold
Jan 30Estimating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Jan 19Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Jan 04Cooper Cos. initiated at buy at Mizuho on contact lenses, cataract implants positioning
Dec 22Is It Too Late To Consider Buying The Cooper Companies, Inc. (NYSE:COO)?
Dec 20The Cooper Companies declares $0.03 dividend
Dec 14The Cooper Companies Non-GAAP EPS of $2.75 misses by $0.36, revenue of $848.1M beats by $9.22M
Dec 08Cooper Companies: Questions On Viability Of Future Earnings Upside
Nov 04Are Investors Undervaluing The Cooper Companies, Inc. (NYSE:COO) By 38%?
Oct 18BioSkryb, Cooper ink license deal for genomic technology for women's reproductive health
Oct 18Be Wary Of Cooper Companies (NYSE:COO) And Its Returns On Capital
Oct 03The Cooper Companies Non-GAAP EPS of $3.19 misses by $0.04, revenue of $843.4M beats by $13.18M
Aug 31Is Now The Time To Look At Buying The Cooper Companies, Inc. (NYSE:COO)?
Aug 30Cooper Companies: The Perfect Harbor For A Perfect Storm
Aug 18Cooper Companies (NYSE:COO) Seems To Use Debt Quite Sensibly
Aug 03The Cooper Companies declares $0.03 dividend
Jul 13Are The Cooper Companies, Inc. (NYSE:COO) Investors Paying Above The Intrinsic Value?
Jul 07Some Investors May Be Worried About Cooper Companies' (NYSE:COO) Returns On Capital
Jun 23Cooper Companies: Eyeing Above Market Growth, But Fairly Priced At $340
Jun 09Revenue & Expenses BreakdownBeta
Revenue & Expenses Breakdown
BetaHow Cooper Companies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Jan 24 | 3,666 | 291 | 1,580 | 145 |
| 31 Oct 23 | 3,593 | 294 | 1,530 | 137 |
| 31 Jul 23 | 3,514 | 275 | 1,488 | 130 |
| 30 Apr 23 | 3,427 | 288 | 1,467 | 122 |
| 31 Jan 23 | 3,380 | 375 | 1,350 | 116 |
| 31 Oct 22 | 3,308 | 386 | 1,338 | 110 |
| 31 Jul 22 | 3,219 | 431 | 1,297 | 107 |
| 30 Apr 22 | 3,139 | 948 | 1,238 | 103 |
| 31 Jan 22 | 3,029 | 939 | 1,205 | 98 |
| 31 Oct 21 | 2,923 | 2,945 | 1,142 | 93 |
| 31 Jul 21 | 2,845 | 2,916 | 1,122 | 93 |
| 30 Apr 21 | 2,660 | 2,355 | 1,054 | 90 |
| 31 Jan 21 | 2,465 | 2,249 | 997 | 93 |
| 31 Oct 20 | 2,431 | 238 | 991 | 93 |
| 31 Jul 20 | 2,441 | 278 | 937 | 91 |
| 30 Apr 20 | 2,542 | 343 | 972 | 91 |
| 31 Jan 20 | 2,672 | 454 | 981 | 88 |
| 31 Oct 19 | 2,653 | 467 | 993 | 87 |
| 31 Jul 19 | 2,613 | 446 | 981 | 86 |
| 30 Apr 19 | 2,594 | 427 | 957 | 87 |
| 31 Jan 19 | 2,571 | 366 | 944 | 87 |
| 31 Oct 18 | 2,533 | 140 | 973 | 85 |
| 31 Jul 18 | 2,443 | 128 | 907 | 81 |
| 30 Apr 18 | 2,339 | 131 | 864 | 76 |
| 31 Jan 18 | 2,230 | 175 | 823 | 72 |
| 31 Oct 17 | 2,139 | 373 | 799 | 69 |
| 31 Jul 17 | 2,096 | 345 | 756 | 68 |
| 30 Apr 17 | 2,055 | 329 | 739 | 67 |
| 31 Jan 17 | 2,016 | 298 | 726 | 67 |
| 31 Oct 16 | 1,967 | 274 | 711 | 65 |
| 31 Jul 16 | 1,904 | 250 | 679 | 63 |
| 30 Apr 16 | 1,851 | 207 | 666 | 64 |
| 31 Jan 16 | 1,801 | 194 | 656 | 64 |
| 31 Oct 15 | 1,797 | 204 | 661 | 65 |
| 31 Jul 15 | 1,810 | 198 | 659 | 67 |
| 30 Apr 15 | 1,780 | 241 | 655 | 66 |
| 31 Jan 15 | 1,758 | 259 | 648 | 66 |
| 31 Oct 14 | 1,718 | 270 | 639 | 66 |
| 31 Jul 14 | 1,661 | 296 | 632 | 64 |
| 30 Apr 14 | 1,640 | 297 | 623 | 63 |
| 31 Jan 14 | 1,611 | 293 | 618 | 61 |
| 31 Oct 13 | 1,588 | 296 | 610 | 59 |
| 31 Jul 13 | 1,571 | 311 | 601 | 57 |
| 30 Apr 13 | 1,537 | 289 | 593 | 55 |
Quality Earnings: COO has high quality earnings.
Growing Profit Margin: COO's current net profit margins (7.9%) are lower than last year (11.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: COO's earnings have declined by 2.5% per year over the past 5 years.
Accelerating Growth: COO's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: COO had negative earnings growth (-22.5%) over the past year, making it difficult to compare to the Medical Equipment industry average (6.3%).
Return on Equity
High ROE: COO's Return on Equity (3.8%) is considered low.